|
Name |
Chermesinone C
|
Molecular Formula | C18H22O6 | |
IUPAC Name* |
(1S,6aR,9S,9aR,9bS)-1-hydroxy-3,6a-dimethyl-9-[(2S)-2-methylbutanoyl]-1,9,9a,9b-tetrahydrofuro[2,3-h]isochromene-6,8-dione
|
|
SMILES |
CC[C@H](C)C(=O)[C@@H]1[C@H]2[C@@H]3[C@H](OC(=CC3=CC(=O)[C@@]2(OC1=O)C)C)O
|
|
InChI |
InChI=1S/C18H22O6/c1-5-8(2)15(20)13-14-12-10(6-9(3)23-16(12)21)7-11(19)18(14,4)24-17(13)22/h6-8,12-14,16,21H,5H2,1-4H3/t8-,12+,13-,14+,16-,18-/m0/s1
|
|
InChIKey |
POKFFFWIOJPOJZ-OADPAQMCSA-N
|
|
Synonyms |
Chermesinone C; CHEMBL1801781; CHEBI:67398; DTXSID901101713; BDBM50347538; Q27135859; 1300040-80-5; 1H-Furo[2,3-h]-2-benzopyran-6,8(6aH,9H)-dione, 9a,9b-dihydro-1-hydroxy-3,6a-dimethyl-9-[(2S)-2-methyl-1-oxobutyl]-, (1S,6aR,9S,9aR,9bS)-; rel-(1S,6aR,9S,9aR,9bS)-1-hydroxy-3,6a-dimethyl-9-[(2S)-2-methylbutanoyl]-9a,9b-dihydro-1H-furo[2,3-h]isochromene-6,8(6aH,9H)-dione
|
|
CAS | 1300040-80-5 | |
PubChem CID | 53355011 | |
ChEMBL ID | CHEMBL1801781 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 334.4 | ALogp: | 1.5 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 24 | QED Weighted: | 0.628 |
Caco-2 Permeability: | -4.798 | MDCK Permeability: | 0.00001480 |
Pgp-inhibitor: | 0.923 | Pgp-substrate: | 0.074 |
Human Intestinal Absorption (HIA): | 0.051 | 20% Bioavailability (F20%): | 0.106 |
30% Bioavailability (F30%): | 0.315 |
Blood-Brain-Barrier Penetration (BBB): | 0.604 | Plasma Protein Binding (PPB): | 70.16% |
Volume Distribution (VD): | 1.466 | Fu: | 31.90% |
CYP1A2-inhibitor: | 0.017 | CYP1A2-substrate: | 0.454 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.876 |
CYP2C9-inhibitor: | 0.014 | CYP2C9-substrate: | 0.05 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.077 |
CYP3A4-inhibitor: | 0.112 | CYP3A4-substrate: | 0.536 |
Clearance (CL): | 8.757 | Half-life (T1/2): | 0.821 |
hERG Blockers: | 0.054 | Human Hepatotoxicity (H-HT): | 0.874 |
Drug-inuced Liver Injury (DILI): | 0.893 | AMES Toxicity: | 0.069 |
Rat Oral Acute Toxicity: | 0.596 | Maximum Recommended Daily Dose: | 0.766 |
Skin Sensitization: | 0.58 | Carcinogencity: | 0.371 |
Eye Corrosion: | 0.289 | Eye Irritation: | 0.034 |
Respiratory Toxicity: | 0.809 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002774 | 0.556 | D06WTZ | 0.263 | ||||
ENC005364 | 0.370 | D0K7LU | 0.242 | ||||
ENC002773 | 0.364 | D09WYX | 0.236 | ||||
ENC004374 | 0.358 | D0D2TN | 0.223 | ||||
ENC004373 | 0.341 | D02JNM | 0.217 | ||||
ENC002613 | 0.327 | D0I5DS | 0.212 | ||||
ENC005594 | 0.321 | D0Y7IU | 0.210 | ||||
ENC002329 | 0.307 | D04QNO | 0.210 | ||||
ENC002328 | 0.307 | D02RQU | 0.208 | ||||
ENC005367 | 0.303 | D0E9KA | 0.207 |